1. Home
  2. ICUCW vs SIRI Comparison

ICUCW vs SIRI Comparison

Compare ICUCW & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • SIRI
  • Stock Information
  • Founded
  • ICUCW N/A
  • SIRI 2013
  • Country
  • ICUCW United States
  • SIRI United States
  • Employees
  • ICUCW 19
  • SIRI N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • SIRI Broadcasting
  • Sector
  • ICUCW Health Care
  • SIRI Consumer Discretionary
  • Exchange
  • ICUCW Nasdaq
  • SIRI Nasdaq
  • Market Cap
  • ICUCW N/A
  • SIRI N/A
  • IPO Year
  • ICUCW 2021
  • SIRI 1994
  • Fundamental
  • Price
  • ICUCW $0.03
  • SIRI $21.57
  • Analyst Decision
  • ICUCW
  • SIRI Hold
  • Analyst Count
  • ICUCW 0
  • SIRI 15
  • Target Price
  • ICUCW N/A
  • SIRI $26.90
  • AVG Volume (30 Days)
  • ICUCW N/A
  • SIRI 3.9M
  • Earning Date
  • ICUCW N/A
  • SIRI 05-01-2025
  • Dividend Yield
  • ICUCW N/A
  • SIRI 4.98%
  • EPS Growth
  • ICUCW N/A
  • SIRI N/A
  • EPS
  • ICUCW N/A
  • SIRI N/A
  • Revenue
  • ICUCW N/A
  • SIRI $8,605,000,000.00
  • Revenue This Year
  • ICUCW N/A
  • SIRI N/A
  • Revenue Next Year
  • ICUCW N/A
  • SIRI $0.31
  • P/E Ratio
  • ICUCW N/A
  • SIRI N/A
  • Revenue Growth
  • ICUCW N/A
  • SIRI N/A
  • 52 Week Low
  • ICUCW N/A
  • SIRI $18.69
  • 52 Week High
  • ICUCW N/A
  • SIRI $41.60
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • SIRI 51.78
  • Support Level
  • ICUCW N/A
  • SIRI $20.89
  • Resistance Level
  • ICUCW N/A
  • SIRI $21.85
  • Average True Range (ATR)
  • ICUCW 0.00
  • SIRI 0.82
  • MACD
  • ICUCW 0.00
  • SIRI 0.18
  • Stochastic Oscillator
  • ICUCW 0.00
  • SIRI 79.12

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: